Upvote
Downvote
Senior / Vice President, Clinical Development, Immunology, Vividion Therapeutics
Share Job
- Suggest Revision
- MD/PhD or MD; specialty training in immunology, and preferably in gastroenterology, rheumatology, and/or dermatology, is highly desired
- Founded in 2013 by award-winning scientists at the Scripps Research Institute, Vividion Therapeutics, Inc. is a biopharmaceutical company using novel discovery technologies to unlock high-value targets with precision therapeutics for devastating cancers and immune disorders.
- In August 2021, Bayer AG purchased Vividion, with a record-shattering valuation of $2 billion.
- The arm’s length relationship with Bayer provides contractually guaranteed funding through 2024 and expected funding in perpetuity.
- Significantly, Vividion will maintain its independence from Bayer, thus making this a “best of both worlds” opportunity to innovate in an entrepreneurial and agile biotech environment, but with the dedicated resources, connections, and financial strength of a respected global pharma enterprise.
Active Job
Updated 7 days agoSimilar Job
Relevance
Active